中日友好医院品牌怎么样 申请店铺

我要投票 中日友好医院在男科医院行业中的票数:589 更新时间:2026-01-27
中日友好医院是哪个国家的品牌?「中日友好医院」是 中日友好医院 旗下著名品牌。该品牌发源于北京市,由创始人王院长在1984年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中日友好医院品牌出海!将品牌入驻外推网,定制中日友好医院品牌推广信息,可以显著提高中日友好医院产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

中日友好医院怎么样

始于1984年,卫生健康委员会直属大型综合性三级甲等医院,集医疗/教学/科研/康复/预防保健等于一体的现代化综合性医院


中日友好医院(简称“中日医院”)是国家卫生健康委员会直属大型综合性三级甲等医院,于1984年10月23日开院。

中日医院现编制床位1610张(含北区、西区),集医疗、教学、科研和预防保健等多项功能为一体,并承担中央保健医疗任务、国家卫生应急救援队任务,附设中日友好临床医学研究所,同时还是世界卫生组织戒烟与呼吸疾病预防合作中心、国家卫生计生委远程医疗管理与培训中心。

学术方面,王辰院士等在慢阻肺、哮喘、呼吸系感染、呼吸危重症、间质性肺疾病、肺血管病、戒烟等方面取得突出成就,肺栓塞半量溶栓疗法等多项重要创新进入国际诊疗指南;潘孝仁教授、李光伟教授等历时长达20余年进行的“大庆糖尿病预防研究”,被称为2型糖尿病一级预防的里程碑式研究,是国际医学研究的经典;杨文英教授团队发表于《新英格兰医学杂志》的糖尿病流行病学调查,以科学的数据揭示了我国糖尿病防治的严峻形势;王国相教授等在神经遗传学方面的研究受到国内外广泛关注;晁恩祥教授等参与研制的金花清感方被确证对新甲流有效,在我国新发呼吸道传染病防治工作中做出了突出贡献。

医院的内分泌科、呼吸与危重症医学科、风湿免疫科、老年医学科、急诊医学科、胸外科、疼痛科、中医风湿病科、中西医结合肿瘤内科、中医肺病科、肛肠科、临床护理专业等科室及专业被评为国家临床重点专科建设项目。

中日医院现有副高级技术职称以上人员500余人,硕士研究生学历以上人员1000余人,博士和硕士生导师200余人。医院是北京大学和北京中医药大学的临床医学院,北京协和医学院的教学医院,与北京航空航天大学等国内学术机构建立战略合作关系,与日本、美国、英国等多个医疗机构和大学建立了友好合作关系。

医院是北京市A类定点医疗机构。当前,全院上下秉承“昌明进取,正道力行”的院训和“以教为政,为职工建设良好的事业发展平台”的核心管理理念,以“照护生命与健康”为使命,确立而立之后“一年转观念、二年入轨道、三年开局面”的阶段性发展目标,构建以业务技术管理体系和经济经营管理体系为主要内容的现代医院管理体系,共同创造中日医院更加美好的未来。


Since 1984, China Japan Friendship Hospital (hereinafter referred to as "China Japan Hospital") is a large-scale comprehensive class-A hospital directly under the national health and Health Commission, which was opened on October 23, 1984. China and Japan hospitals now have 1610 beds (including North and west districts), which are integrated with medical, teaching, scientific research, prevention and health care functions, and undertake the tasks of central health care and medical treatment, national health emergency rescue team, attached with China Japan Friendship Clinical Medicine Research Institute, who quit smoking and respiratory disease prevention cooperation center, national health and Family Planning Commission telemedicine Management and training center. Academician Wang Chen has made outstanding achievements in COPD, asthma, respiratory infection, respiratory critical illness, interstitial lung disease, pulmonary vascular disease, smoking cessation, etc. many important innovations such as pulmonary embolism half thrombolytic therapy have entered the international diagnosis and treatment guidelines. Professor Pan Xiaoren, Professor Li Guangwei and other professors have carried out "Daqing diabetes prevention research" for more than 20 years, which is called 2 The landmark research on primary prevention of type 2 diabetes is a classic of international medical research; the diabetes epidemiological survey published by Professor Yang Wenying's team in the New England Journal of medicine reveals the severe situation of diabetes prevention and treatment in China with scientific data; Professor Wang Guoxiang's research on neurogenetics has been widely concerned at home and abroad; Professor Chao Enxiang and others have participated in the research The Jinhua Qinggan formula has been proved to be effective in the prevention and treatment of new respiratory infectious diseases in China. The departments and specialties of Endocrinology, respiratory and critical care medicine, rheumatology and immunology, geriatrics, emergency medicine, thoracic surgery, pain, rheumatism of traditional Chinese medicine, internal oncology of Integrated Chinese and Western medicine, pulmonary disease of traditional Chinese medicine, anorectal surgery, clinical nursing of the hospital are rated as national key clinical specialty construction projects. At present, there are more than 500 people with associate senior technical titles or above, more than 1000 people with master's degree or above, and more than 200 doctors and master's supervisors in China and Japan hospitals. The hospital is the clinical medicine school of Peking University and Beijing University of traditional Chinese medicine, and the teaching hospital of Peking Union Medical College. It has established strategic cooperation relations with domestic academic institutions such as Beijing University of Aeronautics and Astronautics, and has established friendly cooperation relations with multiple medical institutions and universities such as Japan, the United States and the United Kingdom. The hospital is a class a designated medical institution in Beijing. At present, the whole hospital adheres to the core management concepts of "being prosperous and enterprising, being upright and doing our best" and "taking education as the government, building a good career development platform for employees", takes "caring for life and health" as the mission, establishes the phased development goal of "one year to change the concept, two years to track, three years to start", and constructs the business technology management system and economic economy The modern hospital management system with business management system as its main content will jointly create a better future for Chinese and Japanese hospitals.

本文链接: https://brand.waitui.com/f14617d1c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

阿迪达斯成为2026江苏省城市足球联赛官方战略合作伙伴

36氪获悉,1月27日,阿迪达斯宣布成为2026江苏省城市足球联赛官方战略合作伙伴。数据显示,联赛自2025年创立以来,整个赛季现场观赛人次累计突破243万,场均2.8万人的上座率创省级联赛纪录。线上直播观看人次超22亿,社交平台相关话题播放量突破1000亿。

16分钟前

张江集团、陆家嘴集团在上海成立人工智能创新小镇生态服务公司

36氪获悉,爱企查App显示,近日,上海张江人工智能创新小镇生态服务有限公司成立,法定代表人为陈衡,注册资本1亿元人民币,经营范围包括人工智能双创服务平台、会议及展览服务、组织文化艺术交流活动、科技中介服务等。股东信息显示,该公司由上海张江(集团)有限公司、上海陆家嘴(集团)有限公司共同持股。

16分钟前

金盘科技:筹划发行H股并在香港联合交易所有限公司上市

36氪获悉,金盘科技公告,公司拟在境外发行股份(H股)并在香港联合交易所有限公司主板上市,公司董事会授权公司管理层启动本次H股上市的前期筹备工作,授权期限为自董事会审议通过之日起12个月内。公司计划与相关中介机构就本次H股上市的具体推进工作进行商讨,关于本次H股上市的细节尚未确定。

16分钟前

帝尔激光:筹划发行H股股票并在香港联交所上市

36氪获悉,帝尔激光公告,公司正在筹划发行境外上市外资股(H股)股票并申请在香港联合交易所有限公司主板挂牌上市,以推进国际化战略布局,打造多元化资本运作平台,提升国际品牌形象及全球市场综合竞争力,加快海外业务发展。相关细节尚未确定,本次发行H股并上市不会导致公司控股股东和实际控制人发生变化。该事项尚需提交公司董事会和股东会审议,并需取得相关监管机构备案、批准或核准。

16分钟前

中国移动遭南向资金净卖出11.47亿港元

南向资金今日净卖出6.35亿港元,中国移动、紫金矿业、中芯国际分别遭净卖出11.47亿港元、8.43亿港元、5.53亿港元。净买入方面,腾讯控股、中国人寿、长飞光纤光缆净买入额位列前三,分别获净买入10.24亿港元、5.11亿港元、3.55亿港元。(第一财经)

16分钟前

本页详细列出关于中日友好医院的品牌信息,含品牌所属公司介绍,中日友好医院所处行业的品牌地位及优势。
咨询